1. Home
  2. CCEL vs SYTA Comparison

CCEL vs SYTA Comparison

Compare CCEL & SYTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCEL
  • SYTA
  • Stock Information
  • Founded
  • CCEL 1989
  • SYTA N/A
  • Country
  • CCEL United States
  • SYTA Canada
  • Employees
  • CCEL N/A
  • SYTA N/A
  • Industry
  • CCEL Managed Health Care
  • SYTA Telecommunications Equipment
  • Sector
  • CCEL Health Care
  • SYTA Telecommunications
  • Exchange
  • CCEL Nasdaq
  • SYTA Nasdaq
  • Market Cap
  • CCEL 39.9M
  • SYTA 38.2M
  • IPO Year
  • CCEL 1997
  • SYTA 2020
  • Fundamental
  • Price
  • CCEL $4.90
  • SYTA $3.44
  • Analyst Decision
  • CCEL Strong Buy
  • SYTA
  • Analyst Count
  • CCEL 1
  • SYTA 0
  • Target Price
  • CCEL $8.50
  • SYTA N/A
  • AVG Volume (30 Days)
  • CCEL 7.1K
  • SYTA 1.1M
  • Earning Date
  • CCEL 07-15-2025
  • SYTA 08-19-2025
  • Dividend Yield
  • CCEL 12.50%
  • SYTA N/A
  • EPS Growth
  • CCEL N/A
  • SYTA N/A
  • EPS
  • CCEL N/A
  • SYTA N/A
  • Revenue
  • CCEL $31,988,783.00
  • SYTA $11,740,024.00
  • Revenue This Year
  • CCEL $1.75
  • SYTA $18.41
  • Revenue Next Year
  • CCEL N/A
  • SYTA N/A
  • P/E Ratio
  • CCEL N/A
  • SYTA N/A
  • Revenue Growth
  • CCEL 1.10
  • SYTA 33.58
  • 52 Week Low
  • CCEL $4.68
  • SYTA $0.93
  • 52 Week High
  • CCEL $9.43
  • SYTA $41.68
  • Technical
  • Relative Strength Index (RSI)
  • CCEL 48.00
  • SYTA 46.77
  • Support Level
  • CCEL $4.75
  • SYTA $3.20
  • Resistance Level
  • CCEL $5.43
  • SYTA $3.98
  • Average True Range (ATR)
  • CCEL 0.26
  • SYTA 0.30
  • MACD
  • CCEL 0.01
  • SYTA -0.07
  • Stochastic Oscillator
  • CCEL 28.38
  • SYTA 25.46

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About SYTA Siyata Mobile Inc.

Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.

Share on Social Networks: